X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
epoetin-alpha (1219) 1219
humans (1141) 1141
anemia (746) 746
index medicus (700) 700
female (550) 550
anemia - drug therapy (543) 543
quality-of-life (527) 527
male (521) 521
recombinant-human-erythropoietin (517) 517
erythropoietin (504) 504
erythropoietin - therapeutic use (444) 444
middle aged (442) 442
oncology (432) 432
double-blind (417) 417
aged (406) 406
recombinant proteins (359) 359
anemia - etiology (354) 354
urology & nephrology (333) 333
chronic kidney-disease (321) 321
hematinics - therapeutic use (317) 317
hemoglobin (315) 315
cancer (289) 289
treatment outcome (275) 275
placebo-controlled trial (256) 256
adult (251) 251
chemotherapy (243) 243
quality of life (241) 241
darbepoetin alfa (224) 224
erythropoietin - administration & dosage (209) 209
neoplasms - complications (205) 205
hemoglobins - metabolism (204) 204
erythropoietin - analogs & derivatives (203) 203
hemodialysis-patients (201) 201
epoetin alfa (193) 193
mortality (189) 189
darbepoetin-alpha (178) 178
neoplasms - drug therapy (174) 174
cancer-patients (168) 168
erythropoietin - adverse effects (167) 167
pharmacology & pharmacy (166) 166
anemia - blood (161) 161
hemoglobins - analysis (160) 160
hematology (157) 157
aged, 80 and over (156) 156
therapy (154) 154
anemia - chemically induced (151) 151
chronic kidney disease (151) 151
medicine, general & internal (150) 150
hematinics - adverse effects (149) 149
care and treatment (148) 148
community oncology (148) 148
epoetin alpha (144) 144
hematinics - administration & dosage (144) 144
antineoplastic agents - adverse effects (143) 143
erythropoiesis-stimulating agents (138) 138
retrospective studies (133) 133
risk factors (130) 130
anemia - therapy (128) 128
anaemia (119) 119
chemotherapy-induced anemia (119) 119
hemodialysis (119) 119
survival (118) 118
trial (114) 114
fatigue (110) 110
kidney failure, chronic - complications (110) 110
medicine & public health (110) 110
outcomes (105) 105
animals (104) 104
blood transfusion (101) 101
hemoglobin levels (100) 100
renal dialysis (99) 99
research (99) 99
analysis (96) 96
nephrology (95) 95
dialysis patients (94) 94
dose-response relationship, drug (92) 92
drug therapy (91) 91
prospective studies (91) 91
anemia - complications (89) 89
randomized controlled trials as topic (86) 86
darbepoetin alpha (84) 84
health aspects (84) 84
kidney failure, chronic - therapy (84) 84
drug administration schedule (80) 80
kidney diseases (80) 80
prognosis (80) 80
chronic disease (79) 79
dialysis (79) 79
patients receiving chemotherapy (79) 79
prevalence (79) 79
erythropoiesis (76) 76
erythropoiesis - drug effects (76) 76
time factors (75) 75
chronic kidney failure (74) 74
management (74) 74
clinical trials as topic (73) 73
intravenous iron (72) 72
iron (72) 72
stage renal-disease (72) 72
transfusion (72) 72
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1373) 1373
French (36) 36
Spanish (20) 20
German (15) 15
Italian (2) 2
Korean (2) 2
Polish (1) 1
Russian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Anesthesiology, ISSN 0003-3022, 2014, Volume 120, Issue 4, pp. 839 - 851
Background: Patient blood management combines the use of several transfusion alternatives. Integrated use of erythropoietin, cell saver, and/or postoperative... 
ORTHOPEDIC-SURGERY | METAANALYSIS | CELL SALVAGE | DRAINAGE | TRANSFUSION | ARTHROPLASTY | GUIDELINES | ALTERNATIVES | ANESTHESIOLOGY | RANDOMIZED CONTROLLED-TRIAL | EPOETIN-ALPHA
Journal Article
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, ISSN 1046-6673, 06/2019, Volume 30, Issue 6, pp. 907 - 908
Journal Article
American Journal of Kidney Diseases, ISSN 0272-6386, 03/2019, Volume 73, Issue 3, pp. 297 - 299
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 03/2008, Volume 26, Issue 7, pp. 1040 - 1050
Purpose The efficacy and safety of darbepoetin alfa (DA) for treating patients with active cancer and anemia not receiving or planning to receive cytotoxic... 
SURVIVAL | THERAPY | EFFICACY | ONCOLOGY | TRANSFUSION | RECOMBINANT-HUMAN-ERYTHROPOIETIN | RECEPTOR EXPRESSION | HEMOGLOBIN LEVELS | QUALITY-OF-LIFE | PREVALENCE | EPOETIN-ALPHA
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 02/2017, Volume 76, Issue 2, pp. 355 - 363
Journal Article
Journal Article
Journal of the American Society of Nephrology : JASN, ISSN 1046-6673, 06/2019, Volume 30, Issue 6, pp. 1037 - 1048
Background Despite the widespread use of erythropoietin-stimulating agents (ESAs) to treat anemia in patients undergoing hemodialysis, the relative mortality... 
hemodialysis | mortality | erythropoietin-stimulating agents | RECOMBINANT-HUMAN-ERYTHROPOIETIN | UROLOGY & NEPHROLOGY | RISK | OUTCOMES | ANEMIA | LEVEL | EPOETIN-ALPHA | DARBEPOETIN ALPHA | CANCER | STAGE RENAL-DISEASE | BRAIN
Journal Article
Journal of the American Society of Nephrology, ISSN 1046-6673, 12/2018, Volume 29, Issue 12, pp. 2777 - 2779
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 04/2008, Volume 26, Issue 10, pp. 1611 - 1618
Purpose The concomitant use of intravenous (IV) iron as a supplement to erythropoiesis-stimulating agents in patients with chemotherapy-induced anemia is... 
SUPPLEMENTATION | HEMOGLOBIN | CANCER-PATIENTS | ONCOLOGY | TRANSFUSION | RECOMBINANT-HUMAN-ERYTHROPOIETIN | DOUBLE-BLIND | QUALITY-OF-LIFE | PLACEBO-CONTROLLED TRIAL | EPOETIN-ALPHA | PATIENTS RECEIVING CHEMOTHERAPY
Journal Article
Journal of the American Society of Nephrology, ISSN 1046-6673, 10/2018, Volume 29, Issue 10, pp. 2454 - 2457
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2009, Volume 361, Issue 21, pp. 2019 - 2032
Journal Article
ANNALS OF INTERNAL MEDICINE, ISSN 0003-4819, 04/2016, Volume 164, Issue 7, pp. 472 - 472
Background: The efficacy of erythropoietin-stimulating agents (ESAs) for improving health-related quality of life (HRQOL) in anemia of chronic kidney disease... 
HEMOGLOBIN | MEDICINE, GENERAL & INTERNAL | RECOMBINANT-HUMAN-ERYTHROPOIETIN | TARGET LEVEL | HEMODIALYSIS-PATIENTS | DOUBLE-BLIND | RENAL-DISEASE | LEFT-VENTRICULAR MASS | EPOETIN-ALPHA | DARBEPOETIN ALPHA | DIALYSIS
Journal Article